Hypouricemia is an unusually low level of uric acid in the blood, generally defined as a serum concentration at or below 2.0 mg/dL.1PubMed Central. Hypouricemia and Urate Transporters It is considered rare, and most people who have it feel perfectly fine, which is why it often turns up incidentally on routine blood work rather than from any complaint. But “low uric acid” is not always harmless. Depending on the underlying cause, hypouricemia can set the stage for kidney damage after intense physical activity, and a growing body of research links chronically low uric acid to risks that few people would expect from a molecule most of us associate only with gout.
What Uric Acid Actually Does in Your Body
Uric acid is the end product of purine metabolism in humans. When your body breaks down purines, whether from your own cells turning over or from foods like red meat and shellfish, the final step produces uric acid. Most mammals have an enzyme called uricase that breaks uric acid down further into a much more soluble compound. Humans lost functional uricase millions of years ago through multiple independent mutations in ancestral apes, meaning we carry higher baseline uric acid levels than almost any other mammal.2PubMed Central. Evolutionary history and metabolic insights of ancient mammalian uricases
That retained uric acid is not just waste. It acts as one of the major antioxidants in human plasma, scavenging free radicals and binding transition metals that would otherwise promote oxidative damage.3PubMed Central. Uric Acid Puzzle: Dual Role as Anti-oxidant and Pro-oxidant At the same time, uric acid behaves as a pro-oxidant under certain conditions, which is why high levels are linked to gout, hypertension, and cardiovascular disease.4PubMed Central. Uric acid: the oxidant-antioxidant paradox Whether uric acid helps or harms depends on concentration and the local chemical environment: it can neutralize harmful oxidants through a two-electron reaction, yet in other settings it promotes inflammation.5PubMed Central. Is uric acid a true antioxidant? Identification of uric acid oxidation products and their biological effects This dual personality explains why both very high and very low uric acid can be problematic.
Genetic Causes of Hypouricemia
The most well-characterized inherited form is renal hypouricemia, in which the kidneys let too much uric acid spill into the urine instead of reabsorbing it. Two genes account for the great majority of cases.
The first, SLC22A12, encodes a transporter protein called URAT1 that sits in the kidney’s proximal tubule and pulls uric acid back into the bloodstream. Mutations in this gene reduce or eliminate URAT1 function, so uric acid floods into the urine. Both heterozygous (one copy mutated) and homozygous (both copies mutated) variants have been identified, with homozygous carriers typically showing more severe uric acid depletion.6PubMed Central. Clinical and functional characterization of URAT1 variants This form is classified as renal hypouricemia type 1 and was the first to be genetically characterized.
The second gene, SLC2A9, encodes a transporter called GLUT9. Researchers identified it as a cause of hypouricemia after noticing that some patients with clearly renal hypouricemia had no URAT1 mutations at all. Genome-wide studies and linkage analyses pointed to GLUT9, which also handles uric acid reabsorption in the proximal tubule. Loss-of-function mutations in GLUT9 impair urate transport dramatically.7PubMed Central. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia Homozygous mutations in this gene cause an especially severe form of renal hypouricemia (type 2), with serum uric acid sometimes dropping below 0.5 mg/dL.8PubMed Central. Homozygous SLC2A9 mutations cause severe renal hypouricemia
The practical distinction between types 1 and 2 matters because type 2 appears to carry a higher risk of kidney complications. Both types are inherited in an autosomal recessive pattern for their most severe forms, though heterozygous carriers can have mildly low uric acid without obvious problems.
Enzymatic Causes and Xanthinuria
A completely different route to hypouricemia involves producing less uric acid in the first place, rather than losing too much through the kidneys. This happens when the enzyme xanthine oxidoreductase (XOR), which converts xanthine to uric acid, is deficient or absent. The resulting condition is called hereditary xanthinuria.9PubMed Central. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans
In type I xanthinuria, only xanthine oxidoreductase is affected. In type II, a second enzyme (aldehyde oxidase) is also deficient, suggesting a shared cofactor problem.10PubMed Central. Identification of a new mutation in the human xanthine dehydrogenase responsible for xanthinuria type I Either way, the serum uric acid can drop to almost undetectable levels. In two Czech families with type I xanthinuria, for instance, affected members had uric acid concentrations below the laboratory’s detection limit on repeated measurements, with essentially zero enzyme activity in their plasma.11PubMed. Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I
Xanthinuria differs from renal hypouricemia in a clinically important way. Because xanthine, not uric acid, accumulates, people with xanthinuria are at risk for xanthine kidney stones and xanthine deposits in muscle, not for the uric acid-related kidney injury seen in renal hypouricemia. Most cases are mild, and many people never know they have the condition unless a blood test incidentally shows very low uric acid or they develop xanthine stones.
Acquired and Drug-Induced Causes
Not all hypouricemia is genetic. Several medications and medical conditions push uric acid levels down, sometimes dramatically.
The most obvious culprit is overtreatment of high uric acid. Xanthine oxidase inhibitors like allopurinol and febuxostat, uricosuric drugs like probenecid, and injectable uricase enzymes (pegloticase) are all designed to lower uric acid in people with gout. Overshoot happens. But drugs that have nothing to do with gout can also reduce uric acid, including certain antibiotics (trimethoprim-sulfamethoxazole), losartan (an antihypertensive), and high-dose salicylates.12PubMed. Drug-Induced Hypouricemia
Medical conditions that increase uric acid clearance through the kidneys can have the same effect. The syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is best known for causing dangerously low sodium, also causes hypouricemia by ramping up renal uric acid clearance.13PubMed. Mechanisms of hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone Total parenteral nutrition (intravenous feeding) has been documented to cause profound drops in uric acid, sometimes to levels between 1 and 2.7 mg/dL, with values bouncing back within a week of resuming normal feeding.14PubMed. Hypouricemia in total parenteral nutrition
Pregnancy provides another example. In the first trimester, uric acid normally drops to around 3 mg/dL or lower, driven by the effects of estrogen on the kidneys and the increased blood flow that comes with pregnancy.15PubMed Central. Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study This is a physiological shift, not a disease, and uric acid rises again later in pregnancy. It becomes relevant mainly because clinicians tracking uric acid during pregnancy for preeclampsia monitoring need to know that a first-trimester low reading is expected.
The Biggest Complication: Exercise-Induced Kidney Injury
Most people with mild hypouricemia go their entire lives without symptoms. The dangerous exception is exercise-induced acute kidney injury (EIAKI), which is the complication that draws the most clinical concern in renal hypouricemia. The typical scenario: a young, otherwise healthy person engages in strenuous exercise and develops severe flank pain, nausea, and dark urine within hours. Blood tests reveal a sudden spike in creatinine, indicating acute kidney damage.
The proposed mechanism ties back to the kidneys’ handling of uric acid during exertion. In healthy people, vigorous exercise increases uric acid production from muscle breakdown, and the kidneys clear the extra load without trouble. In people with renal hypouricemia, the already high rate of uric acid excretion spikes further during exercise, concentrating urate in the kidney tubules. Researchers have hypothesized that the hypouricemia itself disrupts normal exercise-related blood flow in the kidneys, and that the concentrated urate in the tubular lumen triggers an inflammatory cascade involving the NLRP3 inflammasome and interleukin-1β release.16PubMed Central. Hypothetical Mechanism of Exercise-Induced Acute Kidney Injury Associated with Renal Hypouricemia The combination of impaired blood flow and tubular inflammation leads to the acute kidney injury.
This complication has been reported repeatedly after various forms of intense activity, from distance running and military drills to competitive sports. It tends to be recurrent: without preventive measures, the same person may experience multiple episodes. EIAKI is more commonly reported in type 2 renal hypouricemia (GLUT9 mutations), though it occurs in type 1 as well. In one case report, a patient with compound heterozygous GLUT9 mutations suffered recurrent kidney injury episodes even after relatively low-intensity exercise.17Frontiers in Nephrology. Renal hypouricemia type 2 with SLC2A9 compound heterozygous variants: a case report of recurrent acute kidney injury triggered by low-intensity exercise
How Hypouricemia Is Diagnosed
The starting point is simple: a serum uric acid level at or below 2.0 mg/dL on a blood test. But finding low uric acid raises the question of why it is low, and sorting out the cause requires a few more steps.
The key diagnostic tool is the fractional excretion of uric acid (FEUA), which measures the percentage of filtered uric acid that ends up in the urine rather than being reabsorbed. A FEUA above 10% points strongly toward a renal cause, meaning the kidneys are letting too much uric acid escape.18PubMed. Diagnostic tests for primary renal hypouricemia If FEUA is normal or low, the problem is more likely reduced uric acid production, as seen in xanthinuria. In that case, elevated xanthine in the urine can confirm the enzymatic deficiency.
Identifying the specific urate transporters involved requires genetic testing, which helps distinguish type 1 from type 2 renal hypouricemia.19NefrologÃa (English Edition). Hypouricemia and tubular transport of uric acid This matters practically because the type influences recurrence risk for kidney complications and helps family members understand their own risk. Acquired causes are usually identified from the clinical context: a medication history, the presence of SIADH, or intravenous feeding.
Endothelial Dysfunction and Cardiovascular Concerns
Beyond kidney injury, there is emerging evidence that severely low uric acid impairs blood vessel function. A study of individuals with homozygous or compound heterozygous URAT1 mutations found that those with serum uric acid below 0.8 mg/dL had reduced flow-mediated dilation (a measure of how well blood vessels relax and expand in response to blood flow) compared to people with normal or mildly low uric acid. In the hypouricemia group, uric acid and vessel function were positively correlated, meaning the lower the uric acid, the worse the blood vessels performed.20Circulation Journal. Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia
This finding fits with uric acid’s role as an antioxidant. If uric acid helps protect blood vessel linings from oxidative damage, stripping it away could leave the endothelium more vulnerable. Whether this translates into higher rates of heart attack or stroke over a lifetime is not yet established. The research is still in the observational and mechanistic stage, but it is a concern worth following, especially for people with the most severe genetic forms of hypouricemia.
Connections to Neurological Disease
One of the more striking lines of research links low uric acid levels to a higher risk of Parkinson’s disease. Multiple studies have found that people with lower serum uric acid are more likely to develop Parkinson’s and tend to progress faster once they have it.21PubMed Central. The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review A large nested case-control analysis drawing on over 90,000 participants in US cohorts found that higher urate levels were associated with lower future risk of Parkinson’s in men, though the association was less clear in women.21PubMed Central. The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review This has led some researchers to propose uric acid as a biomarker for Parkinson’s risk and progression.22PubMed Central. Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis
The hypothesis is intuitive: Parkinson’s disease involves oxidative damage to dopamine-producing neurons in the brain, and uric acid’s antioxidant properties could offer some protection. Low uric acid has also been linked to disease activity in multiple sclerosis, another neurological condition with an oxidative and inflammatory component. Lower uric acid correlated with longer disease duration and greater disability in MS patients.23PubMed Central. Uric Acid in Parkinson’s Disease: What Is the Connection?
An important caveat: these associations do not prove that low uric acid causes neurological disease. Uric acid might simply be a marker of some other underlying metabolic state. Clinical trials that attempted to raise uric acid in Parkinson’s patients to see if it slowed disease progression have had mixed results, and the connection remains unresolved. Still, for someone with genetically determined hypouricemia, this is a research area worth being aware of.
Managing Hypouricemia in Daily Life
There is no pill that safely raises uric acid to normal and keeps it there. Management of hypouricemia is therefore mostly about preventing complications, and the strategy depends on the underlying cause.
For people with renal hypouricemia (types 1 and 2), the primary focus is avoiding exercise-induced acute kidney injury. Practical recommendations include staying well-hydrated before, during, and after physical activity, and avoiding sudden bouts of intense exertion. Patient education is the cornerstone: people need to understand that sharp flank pain or dark urine after exercise is a medical emergency, not just a cramp.17Frontiers in Nephrology. Renal hypouricemia type 2 with SLC2A9 compound heterozygous variants: a case report of recurrent acute kidney injury triggered by low-intensity exercise
Allopurinol, the same drug used to treat gout by blocking uric acid production, has been explored as a preventive measure in renal hypouricemia. The logic is counterintuitive at first: why would you suppress uric acid production in someone who already has too little? The idea is that by producing less uric acid, there is less uric acid flooding through the kidney tubules during exercise, reducing the concentration spike that triggers injury. In a small study, daily allopurinol prevented exercise-induced kidney injury in a patient with renal hypouricemia by blunting the surge of urinary urate that occurred during exertion.24PubMed. Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature The evidence base for this approach is thin, consisting of case reports and small case series rather than trials, and some clinicians opt against it due to the lack of robust data.17Frontiers in Nephrology. Renal hypouricemia type 2 with SLC2A9 compound heterozygous variants: a case report of recurrent acute kidney injury triggered by low-intensity exercise
For xanthinuria, the main preventive measure is high fluid intake to reduce the risk of xanthine kidney stones. Avoiding high-purine foods can modestly reduce xanthine production and is generally advised.
In acquired hypouricemia, management usually means addressing the underlying cause. If a medication is responsible, a dose adjustment or drug substitution can bring uric acid back up. If SIADH is the culprit, treating the hormone imbalance corrects the uric acid as well.
Why Hypouricemia Is Underrecognized
One reason hypouricemia flies under the clinical radar is that standard metabolic panels do not always include uric acid. It gets measured when gout or kidney stones are suspected, not as a screening test. A person with renal hypouricemia might go years with serum uric acid well below 2 mg/dL and never know, because they never have it checked.
Compounding the problem, hypouricemia is rare enough that many primary care physicians have seen few or no cases. The reflex when uric acid comes back low is often to shrug it off. Compared to hyperuricemia, which has a well-established association with gout and gets enormous clinical attention, hypouricemia has attracted far less research funding and awareness. The complications it causes, particularly EIAKI, tend to be reported in nephrology and genetics journals rather than mainstream medical education. Young athletes or military recruits are the classic population at risk, but without a diagnosis of hypouricemia already in hand, an episode of exercise-induced kidney injury may be attributed to dehydration or rhabdomyolysis and the underlying cause missed entirely.
Genetic testing has become more accessible and less expensive, which helps once there is a reason to order it. But getting to that point requires a clinician who considers hypouricemia in the first place. If you have had an unexplained episode of kidney injury after exercise, or if routine blood work has incidentally shown very low uric acid, asking specifically about renal hypouricemia and requesting a fractional excretion of uric acid test is a reasonable step.
The Evolutionary Puzzle of Human Uric Acid
The fact that humans have abnormally high uric acid compared to most mammals makes hypouricemia a window into an old evolutionary puzzle. The uricase gene was inactivated by separate mutations in the ancestors of great apes during the Miocene, roughly 15 to 20 million years ago.2PubMed Central. Evolutionary history and metabolic insights of ancient mammalian uricases Researchers have reconstructed ancient uricases and tested them in the lab, finding that the enzyme worked perfectly well before it was silenced. Why natural selection would tolerate losing a functional enzyme, given that the resulting uric acid accumulation causes gout, kidney damage, and cardiovascular disease at high levels, remains debated.
One hypothesis is that higher uric acid provided a survival advantage in periods of fruit scarcity by promoting fat storage and maintaining blood pressure. Another is that the antioxidant benefit of uric acid compensated for the loss of the ability to synthesize vitamin C, which happened in a similar evolutionary timeframe in primates. Whatever the reason, the loss of uricase means that human physiology is built around relatively high uric acid levels. People with genetic hypouricemia are, in a sense, living closer to the biochemistry of our more distant mammalian relatives, with uric acid levels that would be normal in a dog or a mouse but are anomalously low for a human. Whether that is ultimately good, bad, or neutral is something researchers are still working out.